Niramai Health Analytix & Aktion Pink unite to combat breast cancer

NIRAMAI Health Analytix, an innovative health tech startup based out of India, dedicated to early detection of breast cancer, proudly announces its collaboration with Action Pink, a renowned NGO based in Germany. This partnership marks a significant milestone in the global fight against breast cancer.

NIRAMAI, established in 2016, has pioneered a novel radiation-free screening test that is revolutionizing breast cancer screening with its innovative Artificial Intelligence-based technique called Thermalytix®. The mission of NIRAMAI is to enable non-invasive technology enabled solutions for early detection of cancer. Thermalytix is a portable screening test which ensures patient privacy and also offers a painless experience with accurate results. 

Aktion Pink, established in 1999, has been instrumental in raising awareness about breast cancer and advocating for early detection strategies. Led by CEO Corinna Saric, Action Pink empowers individuals with knowledge and resources to combat breast cancer effectively.

The collaboration between NIRAMAI Health Analytix and Action Pink significantly unites efforts to combat breast cancer globally. By combining innovative technology with advocacy and awareness initiatives, the partnership aims to enhance early detection rates and improve outcomes for individuals affected by breast cancer.

“We are thrilled to join forces with Action Pink with our shared mission to create a life-saving impact through awareness creation and early detection of cancer. ” says Dr. Geetha Manjunath, CEO of NIRAMAI Health Analytix.  

“We believe that by working together, we can make a meaningful impact in the fight against breast cancer,” adds Corinna Saric, CEO of Action Pink.

Read More

President of India Interacts With Leading Women Start-ups & Unicorns

The President of India, Smt Droupadi Murmu interacted with a group of women who are founders and co-founders of leading start-ups and unicorns at Rashtrapati Bhavan.
This meeting took place under the initiative “The President with the People” which aims to establish a deeper connect with people and recognise their contributions.
Read more:https://pib.gov.in/PressReleasePage.aspx?PRID=1997259

Read More

Niramai announces ‘Easy Launch kits’ for NGOs to enable Community Screening

Bengaluru, 28th September, 2022: Niramai, the innovative health-tech Indian company which has developed the world-renowned radiation-free, automated and non-invasive breast cancer screening test has launched a new initiative in the October Breast Cancer Awareness Month. Now, community healthcare providers, NGOs and public health workers who are conducting health awareness talks can also perform screening camps in conjunction. This new initiative offers “Easy Launch Kits” for breast cancer screening as a special ‘Starter Kit’ for socially concerned organizations enabling them to provide accurate breast cancer screening services by spending just Rs 1000 per day. This kit enables partner cancer societies, hospitals, diagnostic centers, and NGOs to provide Niramai’s automated breast cancer screening service for unlimited monthly screenings to triage population and identify patients with high suspicion of breast malignancy. This limited period offer with bookings available from 1st – 31st October on ‘First come first serve basis’, will help screenings become accessible and affordable to more women.

Dr. Geetha Manjunath, CEO & Founder, Niramai, said, “It is extremely crucial to encourage more and more women to get screened every year to enable early-stage detection and early treatment intervention which not only save lives but also reduces treatment costs. Early-stage detection makes the person go back to normal life very soon. Since our test provides a “changing room” experience where nobody sees or touches the women during the test, we have so far received excellent feedback from both urban and rural women. There are many socially concerned organizations who actually have similar mission of detecting cancer early, but they were unable to provide free screening services due to the exorbitant costs of hiring a mobile mammography van. With the launch of our Starter Kit, we are enabling a collaborative platform to make screenings accessible and scalable to save thousands of women.  ”

Niramai has been at the forefront of bringing safe, economical, and accessible screening solutions to women across age groups and sections of the society. With this launch, Niramai hopes to impact the lives of more women positively by encouraging them to go for screenings at their nearest diagnostic center, hospital or NGO. Niramai has partnered with reputed healthcare providers such as Apollo Clinics, HCG hospitals, Medall Diagnostics, Rainbow Hospital and Medanta and more, to provide the novel breast cancer screening solution in their facility as well as conduct outreach programs in apartment complex

Niramai has also launched a free whatsapp chatbot for urban women on +91 94834 34444. This is a free “breast health help line” where women can ask any questions related to breast health and evaluate their risk to breast cancer using a validated Machine-Learning-based risk assessment service called with a easy and user-friendly interface through Niramai’s ChatBot. This online assessment test takes only a few minutes and the results are provided within minutes.

Niramai has conducted over 70,000 screenings in India and is operational in over 150 installations at hospitals and diagnostic centres across 29 Indian cities. Niramai also launched Home Screenings service in collaboration with Healthians, Apollo, MiyaraWomen, ProactiveForHer and others.  Niramai has also started international commercial activity in Kenya, UAE, Turkey, UK, Switzerland, Sweden and USA. Niramai is the 1st Indian startup in the female healthcare space to have received regulatory approval from two major global regulatory bodies – the US FDA clearance and the European CE Mark Approval.

Read More